NHP B. Anthracis spore challenge model and perform studies using all RPA vaccine
Ended Awarded Last action
- Contract number
- 00266200309C0005266030061
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $32,960,723
Award facts
- Contract value 162% obligated
- $20,375,746.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- NIAID DEA OA Acquisitions National Institutes of Health, Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $2,536,848 | |
| Other Administrative Action | $0 | |
| Change Order | $17,838,898 | |
| Original award | $12,584,977 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Battelle Memorial Institute a $20.4 million delivery order contract on September 15, 2003, for the development of a Bacillus anthracis spore challenge model and performance studies using the rPA (recombinant protective antigen) vaccine. The contract, which operated on a cost-plus-fixed-fee basis through September 30, 2012, was issued with no set-aside designation, reflecting open competition for this specialized scientific and technical work. Performance was conducted at Battelle's Columbus, Ohio facility, leveraging the organization's extensive capabilities in chemical and biological defense testing and related research services.
This delivery order represents work within Battelle's broader relationship with NIAID, where the institute serves as a key contractor for biological defense research and development initiatives. The contract focused on critical vaccine efficacy evaluation through controlled challenge studies, supporting the federal government's biodefense preparedness objectives. As a nonprofit research and development organization with over 20,000 employees, Battelle was well-positioned to conduct the complex laboratory and technical services required for this anthrax vaccine research program, drawing on its demonstrated expertise in supporting defense and public health agencies with advanced scientific capabilities.
Quick answers
Who was awarded contract 00266200309C0005266030061?
00266200309C0005266030061 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2003.
How much is contract 00266200309C0005266030061 worth?
The government has obligated $32,960,723 on 00266200309C0005266030061. Its current value, with exercised options, is $20,375,746.
Which agency awarded contract 00266200309C0005266030061?
National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded 00266200309C0005266030061, with funding from NIAID DEA OA Acquisitions (National Institutes of Health).
Is contract 00266200309C0005266030061 an order under another contract?
Yes. 00266200309C0005266030061 is a delivery order under 266030061, an indefinite delivery contract.
Was contract 00266200309C0005266030061 competed?
The extent of competition for 00266200309C0005266030061 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award